Kong, Feng-Ming (Spring), MD, PhD
Medical Director, Radiation Oncology Services
Co-Director of Lung and Esophageal Programs
Professor and Chair, Radiation Oncology
Co-Leader of Lung Multidisciplinary Clinic
1120 15th Street, CN 3121
Augusta, GA 30912
Tel (Cancer Center): 706-723-0030
Tel (Radonc Center): 706-721-2971
Feng-Ming (Spring) Kong, MD, PhD, is welcomed to the GRU Cancer Center as the new Chair of Radiation Oncology, Professor of Radiation Oncology, Co-Leader of the GRU Cancer Center Lung Multi-Disciplinary Team, and Co-Director of the GRU Cancer Center Lung and Esophageal Cancer Research Programs. Dr. Kong received her MD and PhD degrees from Fudan University in Shanghai, China, and holds a master’s degree in Clinical Trial Design and Data Analysis from the University of Michigan. Dr. Kong completed residencies at Fudan University and Washington University in St. Louis, a postdoctoral fellowship at Duke University, and an internship at the University of Vermont before joining the University of Michigan Radiation Oncology program, where she became an Associate Professor. Dr. Kong has served as Lead of Thoracic Radiation Oncology Research at University of Michigan Hospitals, Chief of Radiation Oncology at the VA Health Center in Ann Arbor, an expert panelist for the American College of Radiology’s practice appropriateness of lung cancer and practice guidelines on lung cancer, thymoma, and mesothelioma for National Comprehensive Cancer Center Networks, and Chair of the Field Advisory Committee of the National VA Radiation Oncology Program for practice.
Dr. Kong’s academic interests include image-guided and molecular marker-guided individualized adaptive radiation therapy, gene therapy for radiation-induced lung toxicity, predictive biomarkers for survival and treatment side effects of radiation therapy, and modern stereotactic radiation technology to modulate immunofunction. Dr. Kong is the principal investigator of a multicenter clinical trial cosponsored by the Radiation Therapy Oncology Group and the American College of Radiology Imaging Network using PET and modern technology to individualize radiation therapy in non-small cell lung cancer. Dr. Kong is funded both internationally and by the National Institutes of Health for clinical trials related to non-small cell lung cancer. In addition to general radiation oncology and stereotactic body radiation therapy, Dr. Kong’s clinical interests include radiation therapy for lung cancer, esophageal cancer, thymoma, mesothelioma, and other solid tumors.